The Curious Case of CoreWeave’s Stock Surge Amid Corporate Shadows
For behold, as the trumpets of fiscal gain sounded, so too did the clarion calls of potential calamity. News wriggled its way through the corporate ether that the ambitious $9 billion acquisition of Core Scientific might meet resistance-a fact that, paradoxically, ignited glee among some investors. Perhaps, they mused, a lingering doubt is the seed of faster-growing revelations, or simply the stock market’s embrace of stylish unpredictability.